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Background: High linear energy transfer (LET) radiation such as carbon ion particles is successfully used for
treatment of solid tumors. The reason why high LET radiation accomplishes greater tumor-killing than X-rays is still
not completely understood. One factor would be the clustered or complex-type DNA damages. We previously
reported that complex DNA double-strand breaks produced by high LET radiation enhanced DNA end resection,
and this could lead to higher kinase activity of ATR protein recruited to RPA-coated single-stranded DNA. Although
the effect of ATR inhibition on cells exposed to low LET gamma-rays has recently been reported, little is known
regarding the effect of ATR inhibitor on cells treated with high LET radiation. The purpose of this study is to
investigate the effects of the ATR inhibitor VE-821 in human tumor and normal cells irradiated with high LET
carbon ions.
Findings: HeLa, U2OS, and 1BR-hTERT (normal) cells were pre-treated with 1 μM VE-821 for 1 hour and irradiated
with either high LET carbon ions or X-rays. Cell survival, cell cycle distribution, cell growth, and micronuclei
formation were evaluated. VE-821 caused abrogation of G2/M checkpoint and forced irradiated cells to divide into
daughter cells. We also found that carbon ions caused a higher number of multiple micronuclei than X-rays,
leading to decreased cell survival in tumor cells when treated with VE-821, while the survival of irradiated normal
cells were not significantly affected by this inhibitor.
Conclusions: ATR inhibitor would be an effective tumor radiosensitizer with carbon ion irradiation.
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Introduction
More recently the use of charged ion particles for cancer
therapy has been drawing attention. Especially, heavy
charged particles such as carbon ions are successfully
used for treatment of solid tumors [1, 2]. However, the
reason why heavy ion particles have more tumor-killing
effects than X-rays is not completely understood. DNA
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article, unless otherwise stated.radiation is considered to be qualitatively different from
that produced by low LET radiation such as X-rays or
protons. High LET radiation produces complex clustered
damage, and its complexity of DNA damage may affect
cell cycle progression, DNA repair pathways, and cell
death [3].
We previously reported that the complex DNA
double-strand breaks (DSBs) enhance DNA end resec-
tion during the repair process [4]. Other researchers
showed that DNA end complexity determines the speed
of DSB repair and the level of DSB end resection in G2
phase [5], and that cells irradiated with high LET Fe ions
exhibited much greater G2/M accumulation than those
with gamma-rays [6]. These results indicated that cells
irradiated with high LET radiation show higher kinaseicle is distributed under the terms of the Creative Commons Attribution 4.0
ns.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
give appropriate credit to the original author(s) and the source, provide a
indicate if changes were made. The Creative Commons Public Domain
.org/publicdomain/zero/1.0/) applies to the data made available in this
Table 1 D10 with DMSO and RBE
8 h 24 h
D10 DMSO (Gy) RBE D10 DMSO (Gy) RBE
X-ray Carbon X-ray Carbon
HeLa 5.47 2.67 2.05 6.66 2.62 2.54
U20S 3.81 1.64 2.31 4.01 1.64 2.45
1BR-hTERT 3.67 1.90 1.93 3.31 1.79 1.85
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protein, because ATR is recruited to replication protein
A (RPA)-coated single-stranded DNA (ssDNA) [7].
ATR is a DNA damage response kinase that is acti-
vated by DNA damage or replication stress to regulate
the genomic integrity [8]. One of the ATR functions in-
cludes a cell cycle checkpoint after DNA DSBs. After
DNA ends are processed by exonuclease, ATR is re-
cruited to ssDNA and phosphorylates chk1, leading to
cell cycle arrest in G2/M.
A recent report showed that VE-821, a novel ATR in-
hibitor, increased sensitivity to low LET radiation in pan-
creatic cancer cells [9]. This chemical is also known to
inhibit chk1 phosphorylation [10, 11]. Although one re-
port with another ATR inhibitor using normal cells irra-
diated with high LET radiation was recently published
[12], no information with VE-821 using carbon ion irra-
diated tumor cells is available. Thus, we investigated the
effect of VE-821 in tumor cells irradiated with carbon
ions, and found that this drug is an effective radiosensti-
zer when combined with high LET radiation.
Materials and methods
Cell culture, IR irradiations, and drug treatments
HeLa, human cervical cancer cells, and U2OS, human
osteosarcoma cells, were grown in MEM Eagle supple-
mented with 10 % fetal bovine serum plus antibiotics.
HeLa cells were obtained from Cell Resource Center for
Biomedical Research at Tohoku University, Sendai,
Japan, and U2OS cells were obtained from ATCC
(cell line #: HTB-96), USA. 1BR-hTERT, normal hu-
man fibroblasts kindly supplied by Dr. Jeggo, Sussex
University, UK, were grown in DMEM supplemented
with 15 % fetal bovine serum and antibiotics. All cells were
maintained at 37 °C in a humidified CO2 incubator.
290 MeV/u carbon ions (LET of 70 keV/μm) and X-rays by
TITAN-320 (200 kV, 20 mA, Shimadzu) were used for ir-
radiation. Exponentially growing cells were pre-incubated
with 1 μM ATR inhibitor VE-821 (Axon Medchem) or with
DMSO for 1 hour before irradiation.
Colony formation assay
At 8 or 24 hours after irradiation, cells were trypsinized,
counted and plated onto cell culture dishes. After
12 days, cells were fixed in 100 % ethanol and stained
with 0.1 % crystal violet. Colonies containing more than
50 cells were counted as surviving cells.
Cell cycle distribution and cell growth analysis
Cells were irradiated with 3 Gy of carbon ions or 6 Gy
of X-rays and harvested at 12 and 24 hours after irradi-
ation. They were fixed with 70 % cold ethanol and
stained with propidium iodide (PI) (50 μg/ml in PBS
containing 200 μg/ml RNase) for 30 minutes. Then, theywere analyzed on a FACSCalibur (Becton Dickinson) flow
cytometer. For cell growth analysis, the number of cells
was counted by Coulter Counter (Beckman Coulter) im-
mediately and 1 day after irradiation.
Micronucleus assay
Immediately after irradiation of U2OS cells with 1 Gy
of carbon ions or 1 or 2 Gy of X-rays, and 1BR-
hTERT cells with 2 Gy of X-rays, 2 μg/ml of
cytochalasin-B (Cyt-B) was added and cells were incu-
bated for 24 hours. They were then fixed in cold methanol
for 20 minutes, permeabilized in 0.5 % Triton X-100 for
10 minutes on ice, and blocked in 3 % bovine serum albu-
min for 20 minutes at room temperature. They were incu-
bated with anti-β-actin conjugated with Alexa Fluor 488
antibody (Cell Signaling) for 1 hour, and mounted in
ProLong Gold Antifade with DAPI (Molecular Probe).
Results
The ATR inhibitor VE-821 radiosensitized human tumor
cells irradiated with high LET carbon ions
To assess ATR inhibition on radiation sensitivity, cellular
survivals were acquired using a colony formation assay.
Relative biological effectiveness (RBE) based on D10
values, at a dose resulting in one decade of cell killing,
was calculated as X-ray dose leading to 0.1 survival di-
vided by carbon dose leading to 0.1 survival (Table 1).
With 8-hour treatment of VE-821, HeLa cells were
clearly radiosensitized both with carbon ion and X-ray
irradiation, while normal 1BR-hTERT cells were not af-
fected (Fig. 1a). U2OS tumor cells were slightly affected
by VE-821 with 8-hour treatment. Sensitizing enhance-
ment ratios (SER) on the D10 value in carbon ion irradi-
ation are shown in Table 2. With 24-hour treatment of
VE-821, HeLa and U2OS cells were significantly radio-
sensitized by both kinds of radiation, while little was ob-
served in irradiated 1BR-hTERT cells by the inhibitor
(Fig. 1b).
VE-821 abrogated carbon ion-induced G2/M cell cycle
arrest
To investigate the effect of VE-821 on the cell cycle
checkpoint after irradiation, we examined the cell cycle
distribution by flow cytometer. Following carbon ion ir-
radiation, all three cell lines showed significant G2/M
Fig. 1 (See legend on next page.)
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Fig. 1 The ATR inhibitor VE-821 radiosensitized human tumor cells irradiated with high LET carbon ions. HeLa, U2OS, and 1BR-hTERT cells were
pre-treated with 1 μM VE-821 or DMSO for 1 hour before irradiation, and were irradiated with 1, 2, 3 Gy of carbon ions or 2, 4, 6 Gy of X-rays. At
8 hours (a) or 24 hours (b) after irradiation, cells were plated on cell culture dishes to form colonies. Colonies containing more than 50 cells were
counted as surviving cells. Error bars represent standard error of the mean (SEM) of at least three independent experiments. Curves with *show
statistically significant data (p <0.05) when compared with control curves with DMSO only
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the combination with VE-821 decreased the percentage
of G2/M phase, indicating abrogation of G2/M cell cycle
arrest. At 24 hours after irradiation, G2/M arrest contin-
ued in cells without the drug treatment, while cells with
the combination treatment showed high percentages of
G1 cells, the level of which was similar to, or even
higher than non-irradiated control (Fig. 2a). Irradiated
1BR-hTERT cells showed a decrease in the percentage of
S phase and an abrogation of G2/M cell cycle arrest
(Additional file 1: Figure S1). There were no significant
differences in VE-821 effect between the results with 3
Gy carbon ions and with 6 Gy X-rays, reflecting an RBE
value of about 2 for carbon ions. Cellular growth data
seem to indicate that VE-821 forced cells to divide into
daughter cells (Fig. 2b).Carbon ions with VE-821 caused multiple micronuclei
formation
A micronucleus assay of U2OS cells was conducted to
investigate genomic toxicity when treated with VE-821.
In carbon ion-irradiated cells with VE-821, the average
number of micronuclei per binucleated (BN) cell was
3.36 which is about 2.32 times higher than that treated
with DMSO control. In X-ray-irradiated cells with VE-
821, the average number was 1.38 and 2.44 at a dose of
1 and 2 Gy, respectively, 2.39 times and 1.86 times
higher, respectively, than that with DMSO control
(Fig. 3a, 3b). From the results of the percentage of BN
cells with micronuclei, a substantial number of BN cells
with multiple micronuclei were observed in the combin-
ation of VE-821 and irradiation for U2OS tumor cells
(Fig. 3c). We also measured micronuclei formation using
normal 1BR-hTERT cells. As indicated in Fig. 3d, the
micronuclei formation is significantly lower in irradiatedTable 2 D10 withVE-821 and SER
8 h
D10 VE-821 (Gy) SER
X-ray Carbon X-ray Carb
HeLa 4.52 1.96 1.21 1.36
U20S 3.25 1.28 1.17 1.29
1BR-hTERT 3.38 1.78 1.08 1.07normal cells with and without VE-821 treatment when
compared with U2OS tumor cells.
Discussion
In this report we have shown for the first time that pre-
treatment of the ATR inhibitor VE-821 clearly enhanced
the effect of carbon ion irradiation in human tumor
cells. In contrast, little radiosensitization was observed
in normal human cells. Xue et al. [12] showed some
radio-sensitization in different normal human cell line
(GM0639) with carbon ions using another ATR inhibitor
NU6027, but the concentration of the drug is 10 μM
which is ten times higher than this study with VE-821. It
appears that much lower concentration of VE-821 pro-
vides desirable differential effect between normal and
tumor cells.
In cell cycle and growth analysis, we demonstrated
that VE-821 abrogated G2/M cell cycle arrest, forcing
cells to enter mitotic stage. Differences among the three
cell lines were observed in the percentage of G1 phase at
12 hours after irradiation. The percentage of G1 HeLa
cells after irradiation was less than those of U2OS and
1BR-hTERT. This result may be related to the p53 pro-
tein status. U2OS and 1BR-hTERT cells, expressing nor-
mal wild-type p53 protein, manifest both G1/S and G2/M
checkpoint arrest, while HeLa has no or little G1/S check-
point mechanism because HeLa cells express p53, but it is
degraded by E6 proteins [13]. The cell growth data at
1 day after irradiation also showed little cell cycle arrest
when treated with VE-821.
The effects of VE-821 on low LET radiation [11] as
well as VE-821 on Gemcitabine treatment have been re-
ported [9]. Effectiveness of this drug under hypoxic con-
dition was also shown using 3-dimensional spheroids
[14]. In our study SER depended on the treatment time
of ATR inhibitor after irradiation. Much higher SER24 h
D10 VE-821 (Gy) SER
on X-ray Carbon X-ray Carbon
3.45 1.50 1.93 1.74
2.25 0.95 1.78 1.72
3.05 1.46 1.09 1.23
Fig. 2 VE-821 abrogated carbon ion-induced G2/M cell cycle arrest in tumor cells. HeLa and U2OS cells were pre-treated with 1 μM VE-821 or
DMSO for 1 hour before irradiation, and were irradiated with 3 Gy of carbon ions or 6 Gy of X-rays. a Cells were harvested at 12 and 24 hours
after irradiation and their cell cycle distributions were analyzed by flow cytometry. b The number of cells was counted immediately after and
1 day after irradiation. The relative cell number was calculated as follows: cell number after 1 day was divided by cell number immediately after
irradiation. Error bars represent SEM of at least three independent experiments
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irradiation; this trend is more pronounced in tumor
cells than normal cells. By micronucleus analysis,
similar numbers of micronuclei were observed for
1 Gy of carbon-irradiated cells and 2 Gy X-ray-
irradiated cells. This might reflect an RBE value of
carbon ions of around 2. Judging from the compari-
son of micronuclei formation between tumor and
normal cells in Fig. 3d, it seems that tumor cells are
much more genomically unstable, leading to higher
number of chromosome fragmentations than normal
cells, especially when irradiated cells are forced toadvance from G2 to mitotic stage by VE-821 treat-
ment. This manifests in the differences in degree of
radio-sensitization between tumor and normal cells
in Fig. 1, where only tumor cells were significantly
radio-sensitized by VE-821. When ATR activity was
inhibited, high LET radiation caused more multiple
micronuclei in the BN tumor cells. Our studies indi-
cated that the combination of ATR inhibitor and
high LET carbon irradiation provided very effective
tumor control. Thus, ATR inhibition would be a
good alternative for the combined treatment with
low and high LET radiation.
Fig. 3 Carbon ions with VE-821 caused multiple micronuclei formation in tumor cells. a U2OS cells were pre-treated with 1 μM VE-821
or DMSO for 1 hour before irradiation, and were irradiated with 1 Gy of carbon ions, or 1 or 2 Gy of X-rays. They were treated with
cytochalasin-B (2 μg/ml) immediately after irradiation and incubated for 24 hours. Nucleus and β-actin were stained with DAPI and
anti-β-actin antibody. 500 binucleated (BN) cells were scored each time, and this was repeated three times (1500 BN cells were scored
in total). Asterisk(s) in this figure means statistically significant (*: p < 0.05, **: p < 0.01) when the data under the bar were compared.
b Microscopic images of U2OS cells irradiated with 1 Gy of carbon ions and VE-821. Cellular nuclei were stained with DAPI, and β-actin was stained with
anti-β-actin conjugated with Alexa Fluor 488 antibody to detect the cellular surfaces. c Percentages of BN cells with micronuclei were shown as a function
of micronucleus number. d The number of micronuclei in a BN cell was counted in U2OS and 1BR-hTERT cells with the combination of 2 Gy of X-ray
irradiation and DMSO or VE-821 treatment. Error bars represent SEM of at least three independent experiments. Asterisks indicate the same meaning as
in Fig. 3a
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Additional file 1: Figure S1. VE-821 abrogated carbon ion-induced G2/M
cell cycle arrest in 1BR-hTERT cells. 1BR-hTERT cells were pre-treated with 1 μM
VE-821 or DMSO for 1 hour before irradiation, and were irradiated with 3 Gy
of carbon ions or 6 Gy of X-rays. They were harvested at 12 and 24 hours
after irradiation and their cell cycle distributions were analyzed by
flow cytometry. Error bars represent SEM of at least three independent
experiments. (PDF 621 kb)
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